154 related articles for article (PubMed ID: 7311169)
21. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
Kinemuchi H; Sudo M; Yoshino M; Kawaguchi T; Sunami Y; Kamijo K
Life Sci; 1983 Jan; 32(5):517-24. PubMed ID: 6823208
[TBL] [Abstract][Full Text] [Related]
22. Properties of monoamine oxidase in monkey heart.
Katayama M; Kobayashi S; Oguchi K; Yasuhara H
Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
[TBL] [Abstract][Full Text] [Related]
23. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
[TBL] [Abstract][Full Text] [Related]
24. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
25. [Comparative enzymological study of catalytic properties of sturgeon fish liver monoamine oxidases].
Iagodina OV; Basova IN
Zh Evol Biokhim Fiziol; 2013; 49(3):203-10. PubMed ID: 24450221
[TBL] [Abstract][Full Text] [Related]
26. Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data.
Riley LA; Denney RM
Biochem Pharmacol; 1991 Oct; 42(10):1953-9. PubMed ID: 1741773
[TBL] [Abstract][Full Text] [Related]
27. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
Naoi M; Nagatsu T
Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
[TBL] [Abstract][Full Text] [Related]
28. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
[TBL] [Abstract][Full Text] [Related]
29. Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?
Lewinsohn R; Glover V; Sandler M
Biochem Pharmacol; 1980 Mar; 29(5):777-81. PubMed ID: 20227955
[TBL] [Abstract][Full Text] [Related]
30. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
[TBL] [Abstract][Full Text] [Related]
31. [Study of monoamine oxidase from human placenta mitochondria by the chemoluminescence method].
Volkovitskaia OE; Bochev PG; Ribarov SR; Gorkin VZ; Kagan VE
Vopr Med Khim; 1986; 32(5):77-9. PubMed ID: 3776120
[TBL] [Abstract][Full Text] [Related]
32. Studies on beta-phenylethylamine deamination by human placental monoamine oxidase.
Oguchi K; Kobayashi S; Uesato T; Kamijo K
Jpn J Pharmacol; 1981 Feb; 31(1):7-14. PubMed ID: 6788990
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
Naoi M; Nagatsu T
J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of mitochondrial and synaptosomal monoamine oxidase in monkey brain.
Egashira T; Yamamoto T; Yamanaka Y
Jpn J Pharmacol; 1984 Feb; 34(2):211-9. PubMed ID: 6431160
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+).
Morikawa F; Ueda T; Arai Y; Kinemuchi H
Pharmacology; 1986; 32(1):38-45. PubMed ID: 3945672
[TBL] [Abstract][Full Text] [Related]
36. Contribution of monoamine oxidase (MAO) to the binding of tertiary basic drugs in lung mitochondria.
Yoshida H; Kamiya A; Okumura K; Hori R
Pharm Res; 1989 Oct; 6(10):877-82. PubMed ID: 2608630
[TBL] [Abstract][Full Text] [Related]
37. Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems.
Ochiai Y; Itoh K; Sakurai E; Adachi M; Tanaka Y
Biol Pharm Bull; 2006 Dec; 29(12):2362-6. PubMed ID: 17142964
[TBL] [Abstract][Full Text] [Related]
38. RS-2232, a compound with a reversible and specific type-A monoamine oxidase inhibiting property in mouse brain.
Yokoyama T; Iwata N; Kobayashi T
Jpn J Pharmacol; 1987 Aug; 44(4):421-7. PubMed ID: 3682407
[TBL] [Abstract][Full Text] [Related]
39. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP.
Salach JI; Singer TP; Castagnoli N; Trevor A
Biochem Biophys Res Commun; 1984 Dec; 125(2):831-5. PubMed ID: 6335034
[TBL] [Abstract][Full Text] [Related]
40. Evidence for existence of A and B form monoamine oxidase in mitochondria from dog platelets.
Obata T; Egashira T; Yamanaka Y
Jpn J Pharmacol; 1987 Jun; 44(2):105-11. PubMed ID: 3116304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
